首站-论文投稿智能助手
典型文献
Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer
文献摘要:
Prostate cancer(PCa)is one of the most frequent cancers in men,and its biomolecular targets have been extensively studied.This study aimed to analyze the expression of toll-like receptor 9(TLR9)and vascular endothelial growth factor C(VEGF-C)and the clinical value of the coexpression of TLR9 and VEGF-C in PCa.We retrospectively evaluated 55 patients with clinically localized,intermediate-risk,or high-risk PCa who underwent laparoscopic radical prostatectomy(LRP)and extended pelvic lymph node dissection(ePLND)without neoadjuvant hormonal therapy at a single institution from June 2013 to December 2016.In all 55 patients,the median number of lymph nodes(LNs)resected was 23(range:18-31),and a total of 1269 LNs were removed,of which 78 LNs were positive.Seventeen patients had positive LNs,with a positive rate of 30.9%.In addition,the immunohistochemical results in the above patients revealed that high TLR9 expression was correlated with higher Gleason score(GS)(P=0.049),increased LN metastasis(P=0.004),and more perineural invasion(PNI)(P=0.033).Moreover,VEGF-C expression was associated with GS(P=0.040),pathological stage(pT stage)(P=0.022),LN metastasis(P=0.003),and PNI(P=0.001).Furthermore,a significant positive correlation between TLR9 and VEGF-C was found(P<0.001),and the TLR9/VEGF-C phenotype was associated with LN metastasis(P=0.047).Collectively,we propose that TLR9 stimulation may promote LN metastasis in PCa cells through the upregulation of VEGF-C expression,thereby affecting the prognosis of PCa patients.Therefore,these markers may serve as valuable targets for the treatment of PCa.
文献关键词:
作者姓名:
Xian-Zi Zeng;Zhan-Sen Huang;Hong-Peng Fang;Jie-Ying Wu;Qun-Xiong Huang;Chu-Bin Zhuang;Jing Zhou;Jin-Ming Di
作者机构:
Department of Urology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Department of Infertility and Sexual Medicine,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;Department of Pathology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China
引用格式:
[1]Xian-Zi Zeng;Zhan-Sen Huang;Hong-Peng Fang;Jie-Ying Wu;Qun-Xiong Huang;Chu-Bin Zhuang;Jing Zhou;Jin-Ming Di-.Coexpression of TLR9 and VEGF-C is associated with lymphatic metastasis in prostate cancer)[J].亚洲男性学杂志(英文版),2022(04):380-385
A类:
Coexpression,ePLND
B类:
TLR9,VEGF,associated,lymphatic,metastasis,Prostate,PCa,one,most,frequent,cancers,its,biomolecular,targets,have,been,extensively,studied,This,study,aimed,analyze,toll,like,receptor,vascular,endothelial,growth,value,coexpression,We,retrospectively,evaluated,patients,clinically,localized,intermediate,risk,who,underwent,laparoscopic,radical,prostatectomy,LRP,extended,pelvic,dissection,without,neoadjuvant,hormonal,therapy,single,institution,from,June,December,In,median,number,nodes,LNs,resected,was,range,total,were,removed,which,positive,Seventeen,had,rate,addition,immunohistochemical,results,above,revealed,that,correlated,higher,Gleason,score,GS,increased,perineural,invasion,PNI,Moreover,pathological,stage,pT,Furthermore,significant,correlation,between,found,phenotype,Collectively,propose,stimulation,may,promote,cells,through,upregulation,thereby,affecting,prognosis,Therefore,these,markers,serve,valuable,treatment
AB值:
0.551205
相似文献
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Qiong Wang;Zean Li;Jin Yang;Shirong Peng;Qianghua Zhou;Kai Yao;Wenli Cai;Zhongqiu Xie;Fujun Qin;Hui Li;Xu Chen;Kaiwen Li;Hai Huang-Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Pathology,School of Medicine,University of Virginia,Charlottesville,VA 22908,USA;Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Radiation Oncology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China;Department of Urology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China;Department of Radiology,Massachusetts General Hospital,Harvard Medical School,Boston,MA 02114,USA;Department of Urology,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。